HUMAN LIVER MICROSOMAL METABOLISM OF THE ENANTIOMERS OF WARFARIN AND ACENOCOUMAROL - P450 ISOZYME DIVERSITY DETERMINES THE DIFFERENCES IN THEIR PHARMACOKINETICS
Jjr. Hermans et Hhw. Thijssen, HUMAN LIVER MICROSOMAL METABOLISM OF THE ENANTIOMERS OF WARFARIN AND ACENOCOUMAROL - P450 ISOZYME DIVERSITY DETERMINES THE DIFFERENCES IN THEIR PHARMACOKINETICS, British Journal of Pharmacology, 110(1), 1993, pp. 482-490
1 To explain the large differences in (the stereoselectivity of) the c
learances of the enantiomers of warfarin and acenocoumarol (4'-nitrowa
rfarin) their human liver microsomal metabolism has been studied and e
nzyme kinetic parameters determined. The effects of cimetidine, propaf
enone, sulphaphenazole, and omeprazole on their metabolism has been in
vestigated. 2 The 4-hydroxycoumarins follow similar metabolic routes a
nd are mainly hydroxylated at the 6- and 7-position (accounting for 63
to 99% of the metabolic clearances). 3 Due to the lower K(m) values o
f R- and S-acenocoumarol and higher V(max) values of S-acenocoumarol,
the overall metabolic clearances of R/S acenocoumarol exceed those of
R/S warfarin 6 and 66 times respectively. 4 The metabolism of both com
pounds is stereoselective for the S-enantiomers, which is 10 times mor
e pronounced in the case of acenocoumarol. 5 Except for the 7-hydroxyl
ation of the R-enantiomers (r=0.90; P<0.025), the 6- and 7-hydroxylati
on rates of R/S warfarin do not correlate with those of R/S acenocouma
rol. 6 Sulphaphenazole competitively inhibits the 7- and in some sampl
es partly (up to 50%) the 6-hydroxylation of S-warfarin as well as the
7-hydroxylation of R- and S-acenocoumarol and the 6-hydroxylation of
S-acenocoumarol (K(i)s ranging from 0.5- 1.3 mum). 7 Omeprazole partly
(40-80%) inhibits the 6- and 7-hydroxylation of R-warfarin (K(i) = 99
and 117 muM) and of R- (K(i) = 219 and 7.2 mum) and S-acenocoumarol (
K(i) = 6.1 and 7.7 mum) but not S-warfarin in a competitive manner. 8
Differences in the partial (up to 40%) inhibition of the metabolism of
the enantiomers of the 4-hydroxycoumarins were also observed for the
relatively weak inhibitors, propafenone and cimetidine. 9 The results
suggest that the coumarin ring hydroxylations of both compounds are ca
talysed by different combinations of P450 isozymes. The 7-hydroxylatio
n of R/S acenocoumarol and the 6-hydroxylation of S-acenocoumarol are
at least partly conducted by (a) P450 isozyme(s) of the 2C subfamily d
ifferent from P450 2C9 (the main S-warfarin 7- and 6-hydroxylase).